DE-120 Injectable Solution

DE-120 · Santen Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DE-120 Injectable Solution, covering 2018-04-18 to 2018-04-18. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Study of DE-120 Injectable Solution for Age-related Macular Degeneration [Phase 2]